BlackRock Portfolio Management (NASDAQ: ANIK) discloses 4.1% Anika Therapeutics ownership
BlackRock Portfolio Management LLC has filed an amended ownership report for Anika Therapeutics Inc. common stock, disclosing a 4.1% beneficial ownership stake, totaling 544,710 shares. The firm holds sole voting power over 520,622 shares and sole dispositive power over all 544,710 shares. No single …